399 related articles for article (PubMed ID: 29897225)
1. Establishment of a Human iPSC- and Nanofiber-Based Microphysiological Blood-Brain Barrier System.
Qi D; Wu S; Lin H; Kuss MA; Lei Y; Krasnoslobodtsev A; Ahmed S; Zhang C; Kim HJ; Jiang P; Duan B
ACS Appl Mater Interfaces; 2018 Jul; 10(26):21825-21835. PubMed ID: 29897225
[TBL] [Abstract][Full Text] [Related]
2. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
3. An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells.
Canfield SG; Stebbins MJ; Morales BS; Asai SW; Vatine GD; Svendsen CN; Palecek SP; Shusta EV
J Neurochem; 2017 Mar; 140(6):874-888. PubMed ID: 27935037
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a Human Blood-Brain Barrier Co-culture Model Mimicking the Neurovascular Unit Using Induced Pluri- and Multipotent Stem Cells.
Appelt-Menzel A; Cubukova A; Günther K; Edenhofer F; Piontek J; Krause G; Stüber T; Walles H; Neuhaus W; Metzger M
Stem Cell Reports; 2017 Apr; 8(4):894-906. PubMed ID: 28344002
[TBL] [Abstract][Full Text] [Related]
5. An hiPSC-Derived In Vitro Model of the Blood-Brain Barrier.
Goodwin-Trotman M; Patel K; Granata A
Methods Mol Biol; 2022; 2492():103-116. PubMed ID: 35733040
[TBL] [Abstract][Full Text] [Related]
6. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
7. Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D.
Jamieson JJ; Linville RM; Ding YY; Gerecht S; Searson PC
Fluids Barriers CNS; 2019 Jun; 16(1):15. PubMed ID: 31167667
[TBL] [Abstract][Full Text] [Related]
8. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells.
Hollmann EK; Bailey AK; Potharazu AV; Neely MD; Bowman AB; Lippmann ES
Fluids Barriers CNS; 2017 Apr; 14(1):9. PubMed ID: 28407791
[TBL] [Abstract][Full Text] [Related]
9. Barrier Properties and Transcriptome Expression in Human iPSC-Derived Models of the Blood-Brain Barrier.
Delsing L; Dönnes P; Sánchez J; Clausen M; Voulgaris D; Falk A; Herland A; Brolén G; Zetterberg H; Hicks R; Synnergren J
Stem Cells; 2018 Dec; 36(12):1816-1827. PubMed ID: 30171748
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a Human Blood-Brain Barrier Co-Culture Model Mimicking the Neurovascular Unit Using Induced Pluripotent Stem Cells.
Appelt-Menzel A; Cubukova A; Metzger M
Curr Protoc Stem Cell Biol; 2018 Nov; 47(1):e62. PubMed ID: 30261129
[TBL] [Abstract][Full Text] [Related]
11. Electrospun gelatin biopapers as substrate for in vitro bilayer models of blood-brain barrier tissue.
Bischel LL; Coneski PN; Lundin JG; Wu PK; Giller CB; Wynne J; Ringeisen BR; Pirlo RK
J Biomed Mater Res A; 2016 Apr; 104(4):901-9. PubMed ID: 26650896
[TBL] [Abstract][Full Text] [Related]
12. A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-α and IL-6 in an iPSC-based blood-brain barrier model.
Mantle JL; Lee KH
Neurobiol Dis; 2018 Nov; 119():113-120. PubMed ID: 30075293
[TBL] [Abstract][Full Text] [Related]
13. Real-time acquisition of transendothelial electrical resistance in an all-human,
Maherally Z; Fillmore HL; Tan SL; Tan SF; Jassam SA; Quack FI; Hatherell KE; Pilkington GJ
FASEB J; 2018 Jan; 32(1):168-182. PubMed ID: 28883042
[TBL] [Abstract][Full Text] [Related]
14. Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties.
Burkhart A; Thomsen LB; Thomsen MS; Lichota J; Fazakas C; Krizbai I; Moos T
Fluids Barriers CNS; 2015 Aug; 12():19. PubMed ID: 26246240
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Modeling of Blood-Brain Barrier with Human iPSC-Derived Endothelial Cells, Pericytes, Neurons, and Astrocytes via Notch Signaling.
Yamamizu K; Iwasaki M; Takakubo H; Sakamoto T; Ikuno T; Miyoshi M; Kondo T; Nakao Y; Nakagawa M; Inoue H; Yamashita JK
Stem Cell Reports; 2017 Mar; 8(3):634-647. PubMed ID: 28238797
[TBL] [Abstract][Full Text] [Related]
16. Establishing Co-Culture Blood-Brain Barrier Models for Different Neurodegeneration Conditions to Understand Its Effect on BBB Integrity.
Park JS; Choe K; Khan A; Jo MH; Park HY; Kang MH; Park TJ; Kim MO
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982361
[TBL] [Abstract][Full Text] [Related]
17. Advances in blood-brain barrier modeling in microphysiological systems highlight critical differences in opioid transport due to cortisol exposure.
Brown JA; Faley SL; Shi Y; Hillgren KM; Sawada GA; Baker TK; Wikswo JP; Lippmann ES
Fluids Barriers CNS; 2020 Jun; 17(1):38. PubMed ID: 32493346
[TBL] [Abstract][Full Text] [Related]
18. The blood-brain barrier studied in vitro across species.
Thomsen MS; Humle N; Hede E; Moos T; Burkhart A; Thomsen LB
PLoS One; 2021; 16(3):e0236770. PubMed ID: 33711041
[TBL] [Abstract][Full Text] [Related]
19. Luteolin Inhibits Fibrillary β-Amyloid
Zhang JX; Xing JG; Wang LL; Jiang HL; Guo SL; Liu R
Molecules; 2017 Feb; 22(3):. PubMed ID: 28245546
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Influence of Astrocytes on
García-Salvador A; Domínguez-Monedero A; Gómez-Fernández P; García-Bilbao A; Carregal-Romero S; Castilla J; Goñi-de-Cerio F
Altern Lab Anim; 2020 Jul; 48(4):184-200. PubMed ID: 33136430
[No Abstract] [Full Text] [Related]
[Next] [New Search]